Cyclacel Pharmaceuticals (NASDAQ: CYCC ) (NASDAQ: CYCCP ) today announced that it has entered into a common stock purchase agreement (the Purchase Agreement) with Aspire Capital Fund, LLC (Aspire). Aspire has committed to purchase up to $20 million of Cyclacel's common stock from time to time as